NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded three grants totaling more than $1.3 million to researchers pursuing high-risk cancer research involving genomics, proteomics, and metabolomics, the foundation said today.

The 2010 Damon Runyon-Rachleff Innovation Awards will give three investigators grants of $450,000, to be spread out over three years at $150,000 per year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.